Skip to main content
iwCLL 2023 Main banner
Final Program


iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Philip Thompson, MBBS (Hons)

Consultant Haematologist
Department of Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre and The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne
Melbourne, Victoria, Australia

Philip Thompson is an Associate Professor of Haematology in the Sir Peter MacCallum Department of Oncology, University of Melbourne and a Clinical Haematologist at The Peter MacCallum Cancer Centre and Royal Melbourne Hospitals in Melbourne, Australia. After graduating from The University of Melbourne and completing Residency and Haematology training in Melbourne, he undertook a Leukemia Fellowship at M.D. Anderson Cancer Center in Houston, before joining the Faculty at M.D. Anderson from 2015-2023. There, he described the functional cure of patients with low-risk CLL after FCR chemoimmunotherapy and developed research interests in the treatment of high-risk CLL and Richter Transformation, and the development MRD-adapted treatment approaches. Dr. Thompson has led several clinical trials in these areas and has authored or co-authored more than 100 papers.

Presentation(s):